AU2001261020A1 - Platelet function assay and reagent therefor - Google Patents

Platelet function assay and reagent therefor

Info

Publication number
AU2001261020A1
AU2001261020A1 AU2001261020A AU6102001A AU2001261020A1 AU 2001261020 A1 AU2001261020 A1 AU 2001261020A1 AU 2001261020 A AU2001261020 A AU 2001261020A AU 6102001 A AU6102001 A AU 6102001A AU 2001261020 A1 AU2001261020 A1 AU 2001261020A1
Authority
AU
Australia
Prior art keywords
ligand
platelet
platelet function
piop
von willebrand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261020A
Other languages
English (en)
Inventor
Donald E. Mahan
Michael W Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaNetics Inc
Original Assignee
PharmaNetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmaNetics Inc filed Critical PharmaNetics Inc
Publication of AU2001261020A1 publication Critical patent/AU2001261020A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001261020A 2000-05-09 2001-05-09 Platelet function assay and reagent therefor Abandoned AU2001261020A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20263800P 2000-05-09 2000-05-09
US60202638 2000-05-09
PCT/US2001/011760 WO2001086248A2 (en) 2000-05-09 2001-05-09 Platelet function assay and reagent therefor

Publications (1)

Publication Number Publication Date
AU2001261020A1 true AU2001261020A1 (en) 2001-11-20

Family

ID=22750704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261020A Abandoned AU2001261020A1 (en) 2000-05-09 2001-05-09 Platelet function assay and reagent therefor

Country Status (9)

Country Link
EP (1) EP1280931A4 (es)
JP (1) JP2003532891A (es)
KR (1) KR20030014219A (es)
AU (1) AU2001261020A1 (es)
BR (1) BR0110735A (es)
CA (1) CA2408850A1 (es)
MX (1) MXPA02011017A (es)
NO (1) NO20025300L (es)
WO (1) WO2001086248A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
JP4078247B2 (ja) * 2003-05-02 2008-04-23 キヤノン株式会社 磁性体−生体物質複合体型構造体、磁性体に対して結合能を有するアミノ酸配列を有するペプチド断片及びその遺伝子、ならびに磁性体−生体物質複合体型構造体の製造方法
US20120021010A1 (en) * 2010-04-29 2012-01-26 University Of Calcutta Antiplatelet agent and methods of using the same
KR101276179B1 (ko) * 2011-08-08 2013-06-18 고려대학교 산학협력단 혈소판 복합기능 검사 장치 및 방법, 이에 구비되는 미세교반칩
US8772040B2 (en) 2012-08-31 2014-07-08 Korea University Research And Business Foundation Apparatus and method of platelet multi-function analysis, and micro stirring chip

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849340A (en) * 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
TW221493B (es) * 1990-07-10 1994-03-01 Cardiovascular Diagnostics Inc
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
US5446132A (en) * 1992-10-01 1995-08-29 The General Hospital Corporation Thrombin-activated platelet protein-2 (TAPP-2)
US5427913A (en) * 1992-12-03 1995-06-27 Alberta Cancer Board Methods for determining platelet function
WO1994019690A1 (en) * 1993-02-17 1994-09-01 Cardiovascular Diagnostics, Inc. Dry chemistry cascade immunoassay and affinity assay
US5686597A (en) * 1995-06-06 1997-11-11 Incyte Pharmaceuticals, Inc. Thrombin receptor homolog
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US6046051A (en) * 1997-06-27 2000-04-04 Hemosense, Inc. Method and device for measuring blood coagulation or lysis by viscosity changes
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins

Also Published As

Publication number Publication date
WO2001086248A2 (en) 2001-11-15
BR0110735A (pt) 2007-05-08
CA2408850A1 (en) 2001-11-15
JP2003532891A (ja) 2003-11-05
KR20030014219A (ko) 2003-02-15
MXPA02011017A (es) 2004-08-19
EP1280931A4 (en) 2005-02-09
NO20025300L (no) 2003-01-07
EP1280931A2 (en) 2003-02-05
WO2001086248A3 (en) 2002-02-28
NO20025300D0 (no) 2002-11-05

Similar Documents

Publication Publication Date Title
KR100351602B1 (ko) 정확,신속및간결한피브리노겐분석을위한개선된방법및분석시스템
US6586259B1 (en) Platelet/leukocyte interaction assay and reagent therefor
CA2087033C (en) Fibrinogen assays using dry chemical reagents containing magnetic particles
EP2153235B1 (en) Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
Largo et al. Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers
Varon et al. Cone and plate (let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions
US7437913B2 (en) Method and device for analysing a liquid
US10935559B2 (en) Methodologies and reagents for detecting fibrinolysis and hyperfibrinolysis
EP0672170A1 (en) Methods for determining platelet function
AU2001261020A1 (en) Platelet function assay and reagent therefor
US20030211551A1 (en) Platelet function assay and reagent therefor
JP2004506200A (ja) ＧＰＩＩｂ／ＩＩＩａレセプターアンタゴニストの簡易薬剤監視法
van der Vorm et al. Supplementary Methods
Laffan et al. 16 Investigation of haemostasis